OncoMatch/Clinical Trials/NCT05704283

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

Is NCT05704283 recruiting? Yes, currently enrolling (May 2026). This Early Phase 1 trial studies Ultrasound Imaging for breast carcinoma.

Early Phase 1RecruitingMayo ClinicNCT05704283Data as of May 2026

Treatment: Ultrasound Imaging — This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Mayo Clinic in Rochester · Rochester, Minnesota

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify